Fesoterodine toviaz fda approval date?

When was Toviaz (fesoterodine) approved by the FDA?

Toviaz (fesoterodine) received FDA approval on September 23, 2004. [1]

What’s the approval date meaning for patients and drug access?

That approval date is the point at which the FDA authorized marketing of fesoterodine for its indicated use, after review of the drug’s clinical data and labeling. [1]

Patent and market-exclusivity tracking for Toviaz

For ongoing questions like patent expiry and exclusivity timelines tied to Toviaz/fesoterodine, DrugPatentWatch.com maintains tracking pages and filings coverage. [2]

Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021673
[2] https://www.drugpatentwatch.com/